Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$518.81 - $607.81 $28.4 Million - $33.3 Million
54,706 Added 146.2%
92,125 $53.8 Million
Q1 2024

May 15, 2024

SELL
$473.42 - $539.26 $20.2 Million - $23 Million
-42,581 Reduced 53.23%
37,419 $20.1 Million
Q4 2023

Feb 14, 2024

BUY
$437.42 - $470.64 $4.37 Million - $4.71 Million
10,000 Added 14.29%
80,000 $37 Million
Q3 2023

Nov 14, 2023

BUY
$402.4 - $446.42 $28.2 Million - $31.2 Million
70,000 New
70,000 $30.4 Million
Q3 2020

Nov 16, 2020

SELL
$140.89 - $159.9 $12 Million - $13.6 Million
-85,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $2.51 Million - $3.29 Million
20,000 Added 30.77%
85,000 $13 Million
Q1 2020

May 15, 2020

SELL
$115.75 - $170.96 $4.05 Million - $5.98 Million
-35,000 Reduced 35.0%
65,000 $8.79 Million
Q4 2019

Feb 14, 2020

BUY
$130.23 - $153.27 $13 Million - $15.3 Million
100,000 New
100,000 $13.8 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Iron Triangle Partners LP Portfolio

Follow Iron Triangle Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Iron Triangle Partners LP with notifications on news.